| Hamburg n = | Innsbruck n = |
---|---|---|
Total number of cases | 219 | 60 |
Patient data available | 198 | 53 |
Date of surgery: | 1990 - 2003 | 2001 - 2010 |
Age: | Â | Â |
  Mean (year) | 56.8 | 58.7 |
  Median (year) | 56.6 | 58.5 |
  Range | 29.3 - 93.5 | 33 - 84 |
Stage (pT) | Â | Â |
  1 | 51 | 3 |
  2 | 122 | 27 |
  3 | 10 | 28 |
  4 | 10 | 0 |
  Unknown | 5 | 2 |
Nodal status | Â | Â |
  Negative | 137 | 33 |
  Positive | 60 | 25 |
  Unknown | 1 | 2 |
Grading | Â | Â |
  G1 | 20 | 1 |
  G2 | 81 | 42 |
  G3 | 92 | 15 |
  Unknown | 5 | 0 |
Histological type | Â | Â |
  Ductal | 141 | 60 |
  Lobular | 31 | 0 |
  Others | 22 | 0 |
  Unknown | 4 | 0 |
Estrogen receptor (ER) status1 | Â | Â |
  Positive | 149 | 0 |
  Negative | 41 | 60 |
  Unknown | 8 | 0 |
Progesterone receptor (PR) status1 | Â | Â |
  Positive | 125 | 0 |
  Negative | 65 | 60 |
  Unknown | 8 | 0 |
HER2 (ErbB2) status2 | Â | Â |
  Positive | 44 | 0 |
  Negative | 152 | 60 |
  Unknown | 2 | 0 |
Molecular subtype2 | Â | Â |
  Luminal | 121 | 0 |
  HER2-positive | 45 | 0 |
  Triple-negative | 30 | 60 |
  Unknown | 2 | 0 |
Adjuvant chemotherapy | Â | Â |
  Yes | 124 | 56 |
  No | 69 | 2 |
  Unknown | 5 | 2 |
Follow-up period (months) | Â | Â |
  Mean | 120.4 | 67.4 |
  Median | 132.0 | 62.9 |
Recurrences | 72 | 9 |
Died of disease | 56 | 8 |